|Description||venture capital firm|
|Biotech, medical-device and drug-development startups, 3/08||$95M|
|Health-Care Fund, 9/11||$159M|
|Longitude Venture Partners II, 10/12||$385M|
Founded in 2006, Longitude Capital is a venture capital firm that invests in medical device and biotechnology companies developing products that address important unmet medical or economic needs in the life sciences industry.
Longitudeâ€™s investment team has more than 100 years of industry experience and has invested in over 100 life sciences companies. We are active, lead investors who work closely with portfolio companies to achieve corporate objectives and build value for our limited partners.
Our inaugural fund, the $325,000,000 Longitude Venture Partners, L.P., was closed in 2008. Our offices are in Menlo Park, California and Greenwich, Connecticut.
|Esperion Therapeutics||4/13||Venture Round||$33M||6|
|Aptus Endosystems||6/12||Series B||$25M||3|
|Collegium Pharmaceutical||2/12||Venture Round||$22.5M||2|
|Civitas Therapeutics||1/11||Series A||$20M||2|
|Aptus Endosystems||8/10||Series A||$15M||2|
|Solta Medical||3/10||Venture Round||$4.75M||2|
|Solta Medical||1/10||Venture Round||$17.2M||2|